Agrilife24.com:Vaxxinova is proud to announce that Vaxxon® SHS has been named a winner of the 2025 Animal Health Award for Best New Food Animal Product, presented by S&P Global. This recognition highlights our commitment to scientific innovation, resilience, and close collaboration with poultry producers worldwide.
A Breakthrough for Poultry Health:
Vaxxon® SHS is a lyophilized live attenuated Avian Metapneumovirus (aMPV) vaccine, developed to protect poultry against Swollen Head Syndrome. The vaccine has proven itself for more than 20 years in the field outside the US, in multiple poultry production systems.
In 2025, the USDA granted Vaxxinova the first-ever U.S. approval for the importation of a live vaccine for food producing animals, marking an unprecedented regulatory milestone.
Delivering Real Value for Producers:
Producers have reported significant benefits following vaccination programs with Vaxxon® SHS. Vaxxinova also offers an inactivated aMPV vaccine, enabling producers to implement the live vaccine priming and inactivated boost strategy that the industry has long sought.
Vaxxinova: Close to Customers, Committed to Solutions:
This award reflects Vaxxinova’s identity as an agile, global organization rooted in customer partnership. Our mission is to provide reliable, science-driven solutions that meet real health challenges in poultry production. We work closely with veterinarians and producers across markets to ensure our vaccines are effective, practical, and accessible.
Looking Ahead:
The recognition of Vaxxon® SHS as a winner of the 2025 Best New Food Animal Product Award reinforces our commitment to advancing poultry health through innovation, collaboration, and scientific excellence. Vaxxinova thanks their customers for their trust and partnership & also thanks S&P Global for this recognition.